Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808.

Jonathan E Kolitz; Stephen L George; Don M Benson; Kati Maharry; Guido Marcucci; Ravi Vij; Bayard L Powell; Steven L Allen; Daniel J Deangelo; Thomas C Shea; Wendy Stock; Courtney E Bakan; Vera Hars; Eva Hoke; Clara D Bloomfield; Michael A Caligiuri; Richard A Larson

首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808.

【24h】

Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808.

机译：重组白细胞介素-2在60岁以下患者急性髓性白血病患者的患者，癌症和白血病B组19808年的结果。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The efficacy of immunotherapy with rIL-2 administered after intensive postremission treatment was not assessed as planned because of unexpected refusals by patients and/or their physicians to comply with protocol-directed therapy. Neither DFS nor OS was found to be significantly improved.

机译：由于患者和/或其医生的意外拒绝遵守患者指导治疗，未评估免疫治疗后施用的免疫疗法与RIL-2的疗效未被评估。没有发现DFS和OS没有明显改善。

著录项

来源
《Cancer: A Journal of the American Cancer Society》 |2014年第7期|共8页
作者
Jonathan E Kolitz; Stephen L George; Don M Benson; Kati Maharry; Guido Marcucci; Ravi Vij; Bayard L Powell; Steven L Allen; Daniel J Deangelo; Thomas C Shea; Wendy Stock; Courtney E Bakan; Vera Hars; Eva Hoke; Clara D Bloomfield; Michael A Caligiuri; Richard A Larson;
展开▼
作者单位

Don Monti Division of Oncology/Division of Hematology Department of Medicine Hofstra North Shore;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808. [J] . Jonathan E Kolitz, Stephen L George, Don M Benson, Cancer: A Journal of the American Cancer Society . 2014,第7期

机译：首次完全缓解的60岁以下急性髓性白血病患者中的重组白细胞介素2：来自癌症和白血病B组19808的结果。
2. Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808. [J] . Jonathan E Kolitz, Stephen L George, Don M Benson, Cancer: A Journal of the American Cancer Society . 2014,第7期

机译：重组白细胞介素-2在60岁以下患者急性髓性白血病患者的患者，癌症和白血病B组19808年的结果。
3. Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720. [J] . Baer MR, George SL, Caligiuri MA, Journal of Clinical Oncology . 2008,第30期

机译：低剂量白细胞介素2免疫疗法不能改善首次完全缓解的60岁及以上的急性髓样白血病患者的预后：癌症和白血病B组研究9720。
4. Identification of Platelet Factor-4 as an Indicator of Blood Count Recovery in Acute Myeloid Leukemia Patients in Complete Remission [C] . Jin Young Kim, Ho-Jun Song, Hoi-Jeong Lim, ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：血小板因子-4的鉴定为急性髓性白血病患者血统恢复的指标完全缓解
5. Loss of Egr1 plays a role in murine leukemogenesis and may play a role in the development of acute myeloid leukemia and therapy-related acute myeloid leukemia. [D] . Joslin, John M. 2006

机译：Egr1的丢失在小鼠白血病的发生中起作用，并且可能在急性髓细胞性白血病和与治疗有关的急性髓细胞性白血病的发展中起作用。
6. Recombinant Interleukin-2 in Patients Aged Younger Than 60 Years With Acute Myeloid Leukemia in First Complete Remission [O] . Jonathan E. Kolitz, Stephen L. George, Don M. Benson Jr, -1

机译：首次完全缓解的60岁以下急性髓样白血病患者中的重组白细胞介素2
7. Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720 [O] . Baer, Maria R., George, Stephen L., Caligiuri, Michael A., 2008

机译：低剂量白细胞介素2免疫疗法不能改善首次完全缓解的60岁及以上急性髓样白血病患者的治疗效果：癌症和白血病B组研究9720

Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808.

摘要

著录项

相似文献

相关主题

期刊订阅